We are delighted to announce the promotion of Dr. Martin Barrett to Chief Business Officer at Pharmidex.
Martin brings more than 23 years of experience across the pharmaceutical and drug discovery sectors, combining deep scientific expertise with strategic commercial leadership. Throughout his career, he has played a key role in advancing translational science, building strategic partnerships and supporting innovative drug development programmes.
In his new role, Martin will help drive Pharmidex’s continued growth, strengthen collaborations, and expand our capabilities across preclinical pharmacology, toxicology, translational science, and clinical development support.
Congratulations to Martin on this well-deserved promotion. We look forward to the continued impact of his leadership across Pharmidex and the wider drug discovery community.

#Pharmidex #Leadership #BusinessDevelopment #DrugDiscovery #PreclinicalResearch #LifeSciences







